CAPRICOR DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAPR

Rosen Law Firm is notifying investors about multiple securities class action lawsuits. The primary case involves Capricor Therapeutics, which allegedly made false statements about its Deramiocel cell therapy by failing to disclose changes to statistical analysis plans and lack of FDA agreement before resubmitting its Biologics License Application. The lead plaintiff deadline is September 28, 2026. Additional lawsuits involve Innventure, Inc. and Planet Fitness, Inc.